Pages that link to "Q39946620"

The following pages link to ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. (Q39946620):

Displaying 50 items.

• Matrix Metalloproteinases in Non-Neoplastic Disorders (Q26741827) ‎ (← links)
• Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma (Q33655907) ‎ (← links)
• The role of matrix metalloproteinases in atherothrombosis. (Q33805041) ‎ (← links)
• Matrix metalloproteinase-13 predominates over matrix metalloproteinase-8 as the functional interstitial collagenase in mouse atheromata. (Q34009051) ‎ (← links)
• Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries (Q34098485) ‎ (← links)
• Ascending thoracic aortic aneurysms protect against myocardial infarctions (Q34213083) ‎ (← links)
• High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome (Q34437265) ‎ (← links)
• The Extracellular Matrix Regulates Granuloma Necrosis in Tuberculosis. (Q34462437) ‎ (← links)
• Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications (Q34476390) ‎ (← links)
• Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. (Q34480272) ‎ (← links)
• Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction (Q34635631) ‎ (← links)
• MMP-1 drives immunopathology in human tuberculosis and transgenic mice. (Q34876365) ‎ (← links)
• The role of matrix metalloproteinases in vascular disease (Q34981650) ‎ (← links)
• Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke induced lung disease (Q35019702) ‎ (← links)
• S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease (Q35049449) ‎ (← links)
• Mechanisms of plaque vulnerability and rupture (Q35088065) ‎ (← links)
• The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis (Q35170453) ‎ (← links)
• Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling (Q35231067) ‎ (← links)
• Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis (Q35433466) ‎ (← links)
• Metalloproteinases and plasminogen activators in vessel remodeling (Q35574168) ‎ (← links)
• Pathophysiology of plaque rupture and the concept of plaque stabilization (Q35585929) ‎ (← links)
• Calpain inhibition attenuates angiotensin II-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice. (Q35641853) ‎ (← links)
• Changes in the activity of connective tissue matrix enzymes in the metabolic syndrome (Q35674263) ‎ (← links)
• Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives (Q35733486) ‎ (← links)
• Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease (Q36009930) ‎ (← links)
• Atherosclerosis: humoral and cellular factors of inflammation (Q36028330) ‎ (← links)
• The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer (Q36610051) ‎ (← links)
• Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability (Q36752100) ‎ (← links)
• Metalloproteinases and vulnerable atherosclerotic plaques (Q37005370) ‎ (← links)
• Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice (Q37100777) ‎ (← links)
• Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling (Q37304340) ‎ (← links)
• Collagens in the progression and complications of atherosclerosis (Q37368729) ‎ (← links)
• Nkx2-5 Is Expressed in Atherosclerotic Plaques and Attenuates Development of Atherosclerosis in Apolipoprotein E-Deficient Mice. (Q37556387) ‎ (← links)
• Matrix metalloproteinases and peripheral arterial disease (Q37559372) ‎ (← links)
• Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases (Q37769281) ‎ (← links)
• Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae (Q37868606) ‎ (← links)
• Matrix metalloproteinase inhibition therapy for vascular diseases (Q37983293) ‎ (← links)
• Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation (Q38077675) ‎ (← links)
• Molecular biology of atherosclerosis (Q38125279) ‎ (← links)
• Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability (Q38871902) ‎ (← links)
• Ascending Aortic Proaneurysmal Genetic Mutations with Antiatherogenic Effects (Q38958854) ‎ (← links)
• A role of matrix metalloproteinase-8 in atherosclerosis (Q40000765) ‎ (← links)
• Progressive adult-onset emphysema in transgenic mice expressing human MMP-1 in the lung. (Q44391182) ‎ (← links)
• Lovastatin and phospholipase Cgamma regulate constitutive and protein kinase C dependent integrin mediated interactions of human T-cells with collagen (Q44546770) ‎ (← links)
• Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease (Q47223491) ‎ (← links)
• Autoantibodies against aldehyde-modified collagen type IV are associated with risk of development of myocardial infarction. (Q47750132) ‎ (← links)
• Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders. (Q50916304) ‎ (← links)
• Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease. (Q51364804) ‎ (← links)
• Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. (Q55605575) ‎ (← links)
• Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease (Q57169759) ‎ (← links)